enGene Holdings Inc. Warrants

General ticker "ENGNW" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $403.3M (TTM average)

enGene Holdings Inc. Warrants follows the US Stock Market performance with the rate: 6.8%.

Estimated limits based on current volatility of 119.3%: low -0.13$, high 1.47$

Factors to consider:

  • Total employees count: 82 (+43.9%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Inability to raise capital, Product development failure, Clinical trial delays, Manufacturing capability issues, Regulatory and compliance
  • Current price 69.7% below estimated low
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-10-31 to 2026-10-31

  • 2024-10-31 to 2025-10-31 estimated range: [1.09$, 3.57$]
  • 2025-10-31 to 2026-10-31 estimated range: [1.05$, 3.38$]

Similar symbols

Short-term ENGNW quotes

Long-term ENGNW plot with estimates

Financial data

YTD 2023-10-31 2024-10-31 2025-10-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $26.06MM $62.30MM $123.17MM
Operating Income $-26.06MM $-62.30MM $-123.17MM
Non-Operating Income $-73.84MM $7.14MM $5.86MM
Interest Expense $4.95MM $2.80MM $2.99MM
R&D Expense $16.46MM $38.31MM $94.48MM
Income(Loss) $-99.90MM $-55.16MM $-117.30MM
Taxes $0.02MM $-0.02MM $0.00MM
Net Income(Loss)* $-99.92MM $-55.14MM $-117.30MM
Stockholders Equity $72.49MM $272.61MM $167.71MM
Assets $86.96MM $311.17MM $221.47MM
Operating Cash Flow $-24.74MM $-48.28MM $-99.24MM
Capital expenditure $0.32MM $0.93MM $1.49MM
Investing Cash Flow $-0.32MM $-125.95MM $-25.14MM
Financing Cash Flow $86.15MM $265.72MM $1.52MM
Earnings Per Share** $-4.24 $-1.24 $-2.29

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.